Hunter James Kelly Institute is a clinical research site located in Buffalo, New York, United States 14203.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Hunter James Kelly Institute has participated in 1 clinical trials.
Therapeutic areas: Mucopolysaccharidosis Type I (MPS I), Mucopolysaccharidosis Type II (MPS II), Mucopolysaccharidosis Type III (MPS III).
Sponsors: University of Chicago.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Hunter James Kelly Institute has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Hunter James Kelly Institute has 1 clinical trials on record. Their work covers Mucopolysaccharidosis Type I (MPS I), Mucopolysaccharidosis Type II (MPS II), Mucopolysaccharidosis Type III (MPS III).
Hunter James Kelly Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.